COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 77 filers reported holding COMPASS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,759 | -39.8% | 24,243 | 0.0% | 0.02% | -43.3% |
| Q1 2023 | $79,275 | -35.0% | 24,243 | 0.0% | 0.03% | -42.3% |
| Q4 2022 | $121,942 | +121.7% | 24,243 | 0.0% | 0.05% | +73.3% |
| Q3 2022 | $55,000 | -20.3% | 24,243 | 0.0% | 0.03% | -21.1% |
| Q2 2022 | $69,000 | -10.4% | 24,243 | 0.0% | 0.04% | -5.0% |
| Q4 2021 | $77,000 | – | 24,243 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 4,400,000 | $22,132,000 | 17.19% |
| Monashee Investment Management LLC | 2,230,441 | $11,219,000 | 4.83% |
| CHI Advisors LLC | 2,829,712 | $14,233,452 | 3.79% |
| CAXTON CORP | 211,159 | $1,062,132 | 2.71% |
| Orbimed Advisors | 22,362,850 | $112,485,136 | 2.15% |
| Vivo Capital, LLC | 3,557,630 | $17,895 | 2.06% |
| DAFNA Capital Management LLC | 602,051 | $3,028,316 | 0.85% |
| Rock Springs Capital Management LP | 5,333,188 | $26,825,936 | 0.64% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 268,307 | $1,349,584 | 0.39% |
| BRAIDWELL LP | 1,814,266 | $9,125,758 | 0.31% |